3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Leukemia, Myeloid, Acute
17
Myelodysplastic Syndromes
9
Leukemia, Myelomonocytic, Chronic
4
Myeloproliferative Disorders
3
Myelodysplastic-Myeloproliferative Diseases
2
Leukemia, Biphenotypic, Acute
2
Triple Negative Breast Neoplasms
1
Thrombocythemia, Essential
1
Systemic Mastocytosis With an Associated Hematologic Neoplasm
1
Primary Myelofibrosis
1
Polycythemia Vera
1
Mesothelioma, Malignant
1
Mesothelioma
1
Lymphoma, Large B-Cell, Diffuse
1
Lymphoma, B-Cell
1
Hodgkin Disease
1
GATA2 Deficiency
1
Cytopenia
1
Central Nervous System Neoplasms
1
Carcinoma, Non-Small-Cell Lung
1
Carcinoma, Merkel Cell
1
BRCA1 Mutation
1
Anemia, Refractory, with Excess of Blasts
1
Allogeneic Stem Cell Transplantation
1
Interventions
Magnetic Resonance Spectroscopy
54
enzalutamide
47
apalutamide
37
Specimen Handling
37
Androgen Antagonists
34
Abiraterone Acetate
32
Prednisone
29
darolutamide
28
Radiosurgery
27
Pluvicto
23
Docetaxel
23
abiraterone
22
Radiotherapy
21
Leuprolide
19
Biopsy
16
relugolix
14
acetyl-2-naphthylalanyl-3-chlorophenylalanyl-1-oxohexadecyl-seryl-4-aminophenylalanyl(hydroorotyl)-4-aminophenylalanyl(carbamoyl)-leucyl-ILys-prolyl-alaninamide
14
Surveys and Questionnaires
13
gallium 68 PSMA-11
12
Triptorelin Pamoate
12
Gonadotropin-Releasing Hormone
12
Radiation
11
Nivolumab
11
2-(3-(1-carboxy-5-((6-fluoropyridine-3-carbonyl)amino)pentyl)ureido)pentanedioic acid
11
cabazitaxel
10
bicalutamide
10
X-Rays
10
Standard of Care
10
Goserelin
9
Carboplatin
9
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Prostatic Neoplasms
×
decitabine and cedazuridine drug combination
×
90 days
×
Clear all
No trials found.